Organization
International Bio Service
12 clinical trials
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Amlodipine and Valsartan Tablets 10/160 mg and Reference Product (Exforge® 10/160 mg Tablets)Status: Not yet recruiting, Estimated PCD: 2024-07-09
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Dabigatran Etexilate Capsules 150 mg and Reference Product (Pradaxa®) in Healthy Thai Volunteers Under Fasting Conditions and Under Pre-treatment With a Proton Pump InhibitorStatus: Not yet recruiting, Estimated PCD: 2024-10-08
Clinical trial
A Single Dose, Randomized, Open-label, Replicated Crossover Bioequivalence Study of Generic Simvastatin 40 mg Film-coated Tablets and Reference Product (ZOCOR®) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-08-17
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Diacerein 50 mg Capsule and Reference Product (ARTRODAR®) in Healthy Thai Volunteers Under Fed ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-08-03
Clinical trial
A Single Dose, Randomized, Open-label, One-period Parallel Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product (Arava®) in Healthy Thai Male Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-04-23
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Acyclovir 800 mg Tablet and Reference Product (ZoviraxTM) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-02-15
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets and Reference Product (Xatral® XL 10 mg) in Healthy Thai Male Volunteers Under Fed ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-03-14
Clinical trial
A Single Dose, Randomized, Open-label, Two-period, Two-sequence Crossover Bioequivalence Study of Generic Apixaban 5 mg Film-coated Tablets and Reference Product (ELIQUIS) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-09-14
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Celecoxib 200 mg Capsules and Reference Product (CELEBREXTM) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-09-27
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Empagliflozin 25 mg Film-coated Tablets and Reference Product (JARDIANCE®) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-07-05
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Linagliptin 5 mg Film-coated Tablets (LINIPTIN) and Reference Product (Trajenta®) in Healthy Thai Volunteers Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-05-10
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT and Reference Product (Galvus Met®) in Healthy Thai Volunteers Under Fed ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-05-25